Where Do Potent P2Y12 Inhibitors Fit Into Current Practice? - Acute Coronary Syndrome (ACS)
4.9
$ 18.50
In stock
(549)
Product Description
A guided selection of P2Y12i therapy in ACS patients has most favorable profile - PACE-CME
Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis
Ticagrelor Monotherapy Versus Ticagrelor With Aspirin in Acute Coronary Syndrome Patients With a High Risk of Ischemic Events
Where Do Potent P2Y12 Inhibitors Fit Into Current Practice?
Antiplatelet therapy after percutaneous coronary intervention - EuroIntervention
Antiplatelet therapy after percutaneous coronary intervention - EuroIntervention
Pharmacological Treatment of Acute Coronary Syndromes (Current Cardiovascular Therapy): Avanzas, Pablo, Clemmensen, Peter: 9781447154235: : Books
Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy - ScienceDirect
Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome - Bridget Paravattil, Hazem Elewa, 2017
